Loss Per Share	9 Months Ended
Nov. 02, 2024
Earnings Per Share [Abstract]
Loss Per Share	Note 4 – Loss Per Share Basic loss per share is computed by dividing net loss by the weighted average number of shares outstanding during each period presented. Diluted loss per share is computed by dividing net loss by the weighted average number of shares outstanding plus the dilutive effect of stock equivalents outstanding during the applicable periods using the treasury stock method and shares issuable upon conversion of convertible notes payable. Diluted loss per share reflects the potential dilution that could occur if options to purchase stock were exercised into common stock, if outstanding grants of restricted stock were vested and if the incremental shares issuable upon conversion of the currently convertible portion of the convertible notes were issued. Stock options, restricted stock units and the currently convertible portion of the convertible notes that were not included in the computation of diluted loss per share, because to do so would have been antidilutive, were approximately 1,357,000 shares and 695,000 shares for the 13-week periods ended November 2, 2024 and October 28, 2023, respectively and 1,077,000 shares and 696,000 shares for the 39-week periods ended November 2, 2024 and October 28, 2023, respectively.

Loss Per Share

9 Months Ended

Nov. 02, 2024

Note 4 – Loss Per Share

Basic loss per share is computed by dividing net loss by the weighted average number of shares outstanding during each period presented. Diluted loss per share is computed by dividing net loss by the weighted average number of shares outstanding plus the dilutive effect of stock equivalents outstanding during the applicable periods using the treasury stock method and shares issuable upon conversion of convertible notes payable. Diluted loss per share reflects the potential dilution that could occur if options to purchase stock were exercised into common stock, if outstanding grants of restricted stock were vested and if the incremental shares issuable upon conversion of the currently convertible portion of the convertible notes were issued. Stock options, restricted stock units and the currently convertible portion of the convertible notes that were not included in the computation of diluted loss per share, because to do so would have been antidilutive, were approximately 1,357,000 shares and 695,000 shares for the 13-week periods ended November 2, 2024 and October 28, 2023, respectively and 1,077,000 shares and 696,000 shares for the 39-week periods ended November 2, 2024 and October 28, 2023, respectively.